Jan 21, 2021
Marjorie Taylor Greene- Amount
- Receipt pending ingestion
- Filed
- Feb 19, 2021
Congress ticker disclosure profile
As of August 1 at 6:14 AM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference DKNG. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
9
Member filers
2
Disclosed ranges
Amount not disclosed
Most active member desks
6 sells vs 3 buys
Latest trade Jan 21, 2021
Jan 21, 2021
Marjorie Taylor GreeneJan 19, 2021
Alan S. LowenthalJun 29, 2020
Alan S. LowenthalJun 3, 2020
Alan S. LowenthalMay 26, 2020
Alan S. LowenthalMay 20, 2020
Alan S. LowenthalMay 18, 2020
Alan S. LowenthalFeb 3, 2020
Alan S. LowenthalJan 21, 2020
Alan S. Lowenthal| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Jan 21, 2021 | Marjorie Taylor Greene | Buy | Receipt pending ingestion | Feb 19, 2021 | Open card |
| Jan 19, 2021 | Alan S. Lowenthal | Sell | Receipt pending ingestion | Feb 2, 2021 | Receipt pending ingestion |
| Jun 29, 2020 | Alan S. Lowenthal | Sell | Receipt pending ingestion | Jul 8, 2020 | Receipt pending ingestion |
| Jun 3, 2020 | Alan S. Lowenthal | Sell | Receipt pending ingestion | Jun 12, 2020 | Receipt pending ingestion |
| May 26, 2020 | Alan S. Lowenthal | Sell | Receipt pending ingestion | Jun 4, 2020 | Receipt pending ingestion |
| May 20, 2020 | Alan S. Lowenthal | Sell | Receipt pending ingestion | May 28, 2020 | Receipt pending ingestion |
| May 18, 2020 | Alan S. Lowenthal | Sell | Receipt pending ingestion | May 28, 2020 | Receipt pending ingestion |
| Feb 3, 2020 | Alan S. Lowenthal | Buy | Receipt pending ingestion | May 17, 2021 | Open card |
| Jan 21, 2020 | Alan S. Lowenthal | Buy | Receipt pending ingestion | May 17, 2021 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 0 of 9 filed rows include disclosed amount ranges (0.0%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.